Literature DB >> 23786227

Optimal allocation of sample sizes to multicenter clinical trials.

Dejian Lai1, Kuang-Chao Chang, Mohammad H Rahbar, Lemuel A Moye.   

Abstract

In this article, we discuss an approach for optimal sample size allocation in designing multicenter clinical trials. The method we studied was adapted from a stratified sampling survey design. The sample size allocated to centers is a function of the center's treatment cost, the standard deviation of the endpoint, and the availability of patients. We illustrate our approach using two hypothetical scenarios derived from our experiences in designing and conducting multicenter clinical trials. Simulation results are also presented.

Entities:  

Mesh:

Year:  2013        PMID: 23786227      PMCID: PMC3694743          DOI: 10.1080/10543406.2013.789884

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  5 in total

1.  An issue of statistical analysis in controlled multi-centre studies: how shall we weight the centres?

Authors:  Z Lin
Journal:  Stat Med       Date:  1999-02-28       Impact factor: 2.373

2.  Sample size determination for group sequential clinical trials with immediate response.

Authors:  K Kim; D L Demets
Journal:  Stat Med       Date:  1992-07       Impact factor: 2.373

3.  Sample size calculation for multicenter randomized trial: taking the center effect into account.

Authors:  Emilie Vierron; Bruno Giraudeau
Journal:  Contemp Clin Trials       Date:  2006-11-17       Impact factor: 2.226

Review 4.  Some controversies in planning and analysing multi-centre trials.

Authors:  S Senn
Journal:  Stat Med       Date:  1998 Aug 15-30       Impact factor: 2.373

5.  Sizing clinical trials with variable endpoint event rates.

Authors:  L A Moyé
Journal:  Stat Med       Date:  1997-10-30       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.